报 告 人：Dr. Christophe CHESNE，CEO of Biopredic International. Biopredic International
报告时间：2015年11月25日上午9：00
报告地点：RAYBET雷竞技二楼会议室
邀请人：苏 莉教授
简介：Biopredic International is an European leader in development of model in vitro for drug metabolism and toxicity studies, and has unique products such as the HepaRG cells and many proprietary or sophisticated processes related to primary cell culture and the applications of those cells in alternative methods in toxicology. The company originated from a technology transfer of the unit 49 of INSERM (French National Institute of Health and Medical Research), specialised in toxicology and hepatology.